By Dow Jones Business News,
September 05, 2014, 09:34:00 AM EDT
Among the companies with shares expected to actively trade in Friday's session are Family Dollar Stores Inc. (FDO),
Dollar General Corp. (DG) and Dollar Tree Inc. (DLTR).
Family Dollar said its board unanimously rejected Dollar General's revised takeover bid, again citing antitrust
concerns and reiterating its support for a deal with smaller rival Dollar Tree. Family Dollar's shares fell slightly to
$79.65 in premarket trading. Dollar General's shares fell 1.2% to $63.70. Dollar Tree shares were down 0.7% to $54.62.
Starbucks Corp. (SBUX) announced plans to cater to busy commuters by launching smaller, express-style stores. Shares
ticked down slightly to $77.10 premarket.
Intercontinental Exchange Inc. (ICE) said it would acquire SuperDerivatives for about $350 million in cash to expand
its financial market clearing and data services. Shares were inactive premarket.
U.S. regulators on Thursday approved a new kind of cancer drug from Merck & Co. (MRK) that is designed to unleash the
body's immune system against tumors.
Apple Inc. ( AAPL ) said it plans additional steps to keep hackers out of user accounts, but it denied that a lax
attitude toward security had allowed intruders to post nude photos of celebrities on the Internet.
BP PLC ( BP ) was grossly negligent in the 2010 Deepwater Horizon disaster, a federal judge ruled Thursday, handing down
a decision that could cost the company as much as $18 billion in pollution fines for the Gulf of Mexico oil spill.
Kroger Co. (KR) said it is looking to hire 20,000 permanent employees for its growing chain of supermarkets.
Recro Pharma Inc. (REPH) plans to launch a revised study of its lead product candidate, a non-opiod painkiller called
Dex-IN, after an interim analysis of Phase IIb study data showed the treatment's efficacy as a standalone drug wasn't
sufficient to manage severe pain in bunionectomy treatment on the day of surgery.
Institutional Shareholder Services Inc. is recommending against Chiquita Brands International Inc.'s (CQB) deal to buy
Dublin-based Fyffes PLC (FFY.DB).
Prana Biotechnology Ltd. (PRAN) said the Food and Drug Administration granted Orphan Drug designation to its PBT2 drug
for the treatment of Huntington Disease.
Quiksilver Inc. (ZQK) on Thursday reported third-quarter sales were lower than expected, with its Americas and Europe-
Middle East-Africa segments reporting double-digit declines, along with its wholesale channel.
Cooper Cos.'s ( COO ) fiscal third-quarter profit fell slightly, even as revenue at its vision and surgical segments
continued to improve.
El Pollo Loco Holdings Inc.'s (LOCO) second-quarter profit soared, as the regional restaurant chain benefited from
higher sales and lower interest expenses.
Finisar Corp. (FNSR) warned lower demand for telecom products and wireless application transceivers would lead to
lower revenue in its current quarter.
Infoblox Inc. (BLOX) swung to a fiscal fourth-quarter loss, although the network-control products company's results
exceeded its expectations.
Two of luxury-apparel company Michael Kors Holdings Ltd.'s (KORS) majority shareholders will sell off their stock and
step down from the company's board, reducing membership to five from the current seven, the company disclosed on
Thursday in a regulatory filing.
Nvidia Corp. (NVDA) has sued Samsung Electronics Co. and Qualcomm Inc. (QCOM), alleging certain Samsung phones and
tablets are infringing Nvidia patents.
Health-care real-estate investment trust Ventas Inc. (VTR) said a re-audit didn't result in any changes to its
Zumiez Inc.'s (ZUMZ) fiscal second-quarter earnings rose sharply, as the company reported better-than-expected sales,
but its outlook for the current quarter seemed to disappoint.
Write to Tom Rojas at email@example.com and Maria Armental at firstname.lastname@example.org
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
(END) Dow Jones Newswires
Copyright (c) 2014 Dow Jones & Company, Inc.